Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
Authors
Keywords
-
Journal
PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume -, Issue -, Pages 106762
Publisher
Elsevier BV
Online
2023-06-23
DOI
10.1016/j.prostaglandins.2023.106762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration
- (2023) Charles N. Serhan et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation
- (2022) Denise Biagini et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response
- (2022) James Turnbull et al. JOURNAL OF INFECTIOUS DISEASES
- Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions
- (2022) Simon C. Dyall et al. PROGRESS IN LIPID RESEARCH
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
- (2022) Vivian Vasconcelos Costa et al. eLife
- MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis
- (2022) Kimberly Pistorius et al. EBioMedicine
- Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection
- (2022) Luciana P. Tavares et al. mBio
- Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation
- (2022) Mauro Perretti et al. Annual Review of Pharmacology and Toxicology
- Cysteinyl-maresin 3 inhibits IL-13 induced airway hyperresponsiveness through alternative activation of the CysLT1 receptor
- (2022) Jesper Säfholm et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19?
- (2022) David H. Dockrell et al. EUROPEAN RESPIRATORY JOURNAL
- Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease
- (2022) Antonio Recchiuti et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation
- (2021) Nan Chiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
- (2021) Antonio Recchiuti et al. FASEB JOURNAL
- Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19
- (2021) Duco Steven Koenis et al. CIRCULATION RESEARCH
- High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
- (2021) Anne‐Sophie Archambault et al. FASEB JOURNAL
- Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
- (2021) Francesco Palmas et al. PLoS One
- Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice
- (2021) Katherine H. Walker et al. Frontiers in Immunology
- Resolvin T-series Reduce Neutrophil Extracellular Traps
- (2021) Nan Chiang et al. BLOOD
- Concurrent Control of KSHV Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: A New Prospect to the Therapeutic Potential of Lipoxin A4
- (2020) Kumari Asha et al. JOURNAL OF VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
- (2020) Dipak Panigrahy et al. CANCER AND METASTASIS REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Viroporins and inflammasomes: A key to understand virus-induced inflammation
- (2020) N.S. Farag et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
- (2020) Wen Wen et al. Cell Discovery
- Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
- (2020) Evangelos Andreakos et al. ALLERGY
- Specialized pro-resolving mediator network: an update on production and actions
- (2020) Nan Chiang et al. Essays in Biochemistry
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
- (2020) Benjamin Schwarz et al. JOURNAL OF IMMUNOLOGY
- Resolvin D4 attenuates the severity of pathological thrombosis in mice
- (2019) Deya Cherpokova et al. BLOOD
- Concise Review: Pro‐Resolving Lipid Mediators and Receptors in Stem Cell Biology
- (2019) Mario Romano et al. Stem Cells Translational Medicine
- Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes
- (2019) Bruce D. Levy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-β–STAT3-dependent pathway
- (2018) Patrick B. Ampomah et al. FASEB JOURNAL
- Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation
- (2018) Katerina Pyrillou et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression
- (2018) Nina Kim et al. JOURNAL OF IMMUNOLOGY
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
- (2017) Charles N. Serhan FASEB JOURNAL
- Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology
- (2017) Naveen K. Rajasagi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection
- (2017) M Codagnone et al. Mucosal Immunology
- Kaposi sarcoma herpesvirus-associated cancers and related diseases
- (2017) Priscila H. Goncalves et al. Current Opinion in HIV and AIDS
- Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis
- (2016) S Arora et al. CELL DEATH AND DIFFERENTIATION
- Novel Resolvin D2 Receptor Axis in Infectious Inflammation
- (2016) Nan Chiang et al. JOURNAL OF IMMUNOLOGY
- Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection
- (2015) Yumiko Imai BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways
- (2015) Jesmond Dalli et al. FASEB JOURNAL
- Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells
- (2015) Alexandru Marginean et al. Translational Research
- The Specialized Proresolving Mediator 17-HDHA Enhances the Antibody-Mediated Immune Response against Influenza Virus: A New Class of Adjuvant?
- (2014) Sesquile Ramon et al. JOURNAL OF IMMUNOLOGY
- Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection
- (2014) J. Dalli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Resolution of inflammation: an integrated view
- (2013) Almudena Ortega-Gómez et al. EMBO Molecular Medicine
- The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
- (2013) Jesmond Dalli et al. FASEB JOURNAL
- Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology
- (2013) K A Shirey et al. Mucosal Immunology
- Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
- (2012) C. Gudiol et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inflammation 2010: New Adventures of an Old Flame
- (2010) Ruslan Medzhitov CELL
- Controlling Herpes Simplex Virus-Induced Ocular Inflammatory Lesions with the Lipid-Derived Mediator Resolvin E1
- (2010) N. K. Rajasagi et al. JOURNAL OF IMMUNOLOGY
- Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection
- (2010) C. Cilloniz et al. JOURNAL OF VIROLOGY
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
- (2010) Deepali Kumar et al. LANCET INFECTIOUS DISEASES
- Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4- and IFN-β-dependent
- (2010) K A Shirey et al. Mucosal Immunology
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started